Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of TRV045 analgesic effects in healthy adults using PainCart and UVB pain model
NL-OMON60215Phase 1Completed
- Sponsor
- Trevena, Inc.
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of TRV045 in Neuralgia and diabetic polyneuropathy (DPN), sponsored by Trevena, Inc. Primary endpoint: Pharmacodynamic measurements with the UVB pain model. Started Nov 2022; status: completed.
02
Drugs
TRV045
03
Conditions
Neuralgiadiabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on NL-OMON60215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60215.